Ampio Pharmaceuticals (FRA:APH0) Quick Ratio: 2.41 (As of Dec. 2023)


FRA:APH0 Ampio Pharmaceuticals Inc FRA:APH0
35 GF Score
Price €3.62
View Full Analysis

What is Ampio Pharmaceuticals Quick Ratio?

Ampio Pharmaceuticals FRA:APH0 35 Quick Ratio is 2.41 as of Dec. 2023. GuruFocus rates FRA:APH0 with a GF Score™ of 35/100.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Ampio Pharmaceuticals's quick ratio for the quarter that ended in Dec. 2023 was 2.41.

Ampio Pharmaceuticals has a quick ratio of 2.41. It generally indicates good short-term financial strength.

The historical rank and industry rank for Ampio Pharmaceuticals's Quick Ratio or its related term are showing as below:

FRA:APH0's Quick Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.6
* Ranked among companies with meaningful Quick Ratio only.

Ampio Pharmaceuticals  (FRA:APH0) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Ampio Pharmaceuticals Quick Ratio Related Terms


Ampio Pharmaceuticals Quick Ratio Historical Data

* Premium members only.

The historical data trend for Ampio Pharmaceuticals's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ampio Pharmaceuticals Quick Ratio Chart

Ampio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 10.08 6.94 11.18 2.41

Ampio Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.18 4.02 3.67 3.37 2.41

FRA:APH0 vs EFTR, VBIVQ, VRTX: Quick Ratio Comparison

For the Biotechnology subindustry, Ampio Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ampio Pharmaceuticals Quick Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ampio Pharmaceuticals's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Ampio Pharmaceuticals's Quick Ratio falls into.


FRA:APH0
35GF Score
Ampio Pharmaceuticals Inc FRA:APH0
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ampio Pharmaceuticals Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Ampio Pharmaceuticals's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(5.26-0)/2.179
=2.41

Ampio Pharmaceuticals's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(5.26-0)/2.179
=2.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 2.41 mean?
Ampio Pharmaceuticals (FRA:APH0) has a Quick Ratio of 2.41 as of Dec. 2023. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ampio Pharmaceuticals and its competitors.
Is Ampio Pharmaceuticals' Quick Ratio too high?
Ampio Pharmaceuticals' current Quick Ratio is 2.41. The Biotechnology industry median Quick Ratio is 3.60. Ampio Pharmaceuticals' value of 2.41 is 33.1% below this industry median. Overall, Ampio Pharmaceuticals has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Ampio Pharmaceuticals' Quick Ratio compare to EFTR and VBIVQ?
Ampio Pharmaceuticals' Quick Ratio of 2.41 can be compared against companies in the Biotechnology industry. The industry median Quick Ratio is 3.60. Ampio Pharmaceuticals' value of 2.41 is 33.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,416 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ampio Pharmaceuticals's current Quick Ratio of 2.41 is 33.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ampio Pharmaceuticals and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ampio Pharmaceuticals's current Quick Ratio is 2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ampio Pharmaceuticals stock overvalued right now?
Ampio Pharmaceuticals (FRA:APH0) has a current Quick Ratio of 2.41. The current Quick Ratio is 2.41 and 33.1% below the Biotechnology industry median of 3.60. Ampio Pharmaceuticals' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Ampio Pharmaceuticals (FRA:APH0), the current Quick Ratio is 2.41 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ampio Pharmaceuticals Business Description

Address 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201).
35GF Score

Get the complete analysis for FRA:APH0

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.62
Price